Literature DB >> 19184203

Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative period.

H M C Shantha Kumara1, J C Cabot, A Hoffman, M Luchtefeld, M F Kalady, N Hyman, D Feingold, R Baxter, R Larry Whelan.   

Abstract

INTRODUCTION: Plasma vascular endothelial growth factor (VEGF) levels are elevated for 2-4 weeks after minimally invasive colorectal resection (MICR). VEGF induces wound and tumor angiogenesis by binding to endothelial cell (EC)-bound VEGF-receptor 1 (VEGFR1) and VEGFR2. Soluble receptors (sVEGFR1, sVEGFR2) sequester VEGF in the blood and decrease VEGF's proangiogenic effect. The importance of the MICR-related VEGF changes depends on the effect of surgical procedures on sVEGFR1 and sVEGFR2; this study assessed levels of these proteins after MICR for benign indications.
METHODS: Blood samples were taken (n=39) preoperatively (preop) and on postoperative days (POD) 1 and 3; in most cases a fourth sample was drawn between POD 7 and 30. sVEGFR1 and sVEGFR2 levels were measured via enzyme-linked immunosorbent assay (ELISA), which detects free and VEGF bound soluble receptor. Late samples were bundled into POD 7-13 and POD 14-30 time points. Results are reported as mean and standard deviation. The data was assessed with paired-samples t-test.
RESULTS: Preop, mean plasma sVEGFR2 level (9,203.7+/-1,934.3 pg/ml) was significantly higher than the sVEGFR1 value (132.5+/-126.2 pg/ml). sVEGFR2 levels were significantly lower on POD 1 (6,957.8+/-1,947.7 pg/ml,) and POD 3 (7,085.6+/-2,000.2 pg/ml), whereas sVEGFR1 levels were significantly higher on POD 1 (220.0+/-132.8 pg/ml) and POD 3 (182.7+/-102.1 pg/ml) versus preop results. No differences were found on POD 7-13 or 14-30.
CONCLUSIONS: sVEGFR2 values decreased and sVEGFR1 levels increased early after MICR; due to its much higher baseline, the sVEGFR2 changes dominate. The net result is less VEGF bound to soluble receptor and more free plasma VEGF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184203     DOI: 10.1007/s00464-008-0323-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  32 in total

Review 1.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

2.  Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis.

Authors:  Tatsuro Yamaguchi; Hiroko Bando; Takeo Mori; Keiichi Takahashi; Hiroshi Matsumoto; Michiya Yasutome; Herbert Weich; Masakazu Toi
Journal:  Cancer Sci       Date:  2007-03       Impact factor: 6.716

3.  Increased plasma vascular endothelial growth factor among patients with chronic venous disease.

Authors:  S S Shoab; J H Scurr; P D Coleridge-Smith
Journal:  J Vasc Surg       Date:  1998-09       Impact factor: 4.268

4.  Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.

Authors:  J Rak; Y Mitsuhashi; C Sheehan; A Tamir; A Viloria-Petit; J Filmus; S J Mansour; N G Ahn; R S Kerbel
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

Review 5.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Authors:  Daniel J Hicklin; Lee M Ellis
Journal:  J Clin Oncol       Date:  2004-12-07       Impact factor: 44.544

6.  Vascular endothelial growth factor in acute Kawasaki disease.

Authors:  M Terai; K Yasukawa; S Narumoto; S Tateno; S Oana; Y Kohno
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

7.  Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn.

Authors:  S Grad; W Ertel; M Keel; M Infanger; D J Vonderschmitt; F E Maly
Journal:  Clin Chem Lab Med       Date:  1998-06       Impact factor: 3.694

8.  Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.

Authors:  M Detmar; K T Yeo; J A Nagy; L Van de Water; L F Brown; B Berse; B M Elicker; S Ledbetter; H F Dvorak
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

9.  Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection.

Authors:  A Belizon; E Balik; P Horst; D Feingold; T Arnell; T Azarani; V Cekic; R Skitt; S Kumara; R L Whelan
Journal:  Surg Endosc       Date:  2008-01-18       Impact factor: 4.584

10.  Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection.

Authors:  H M C Shantha Kumara; I Kirman; D Feingold; V Cekic; A Nasar; T Arnell; E Balik; A Hoffman; R Baxter; S Conte; R L Whelan
Journal:  Eur J Surg Oncol       Date:  2008-09-07       Impact factor: 4.424

View more
  5 in total

1.  Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection.

Authors:  H M C Shantha Kumara; Jenny C Cabot; Xiaohong Yan; Sonali A C Herath; Martin Luchtefeld; Matthew F Kalady; Daniel L Feingold; Raymond Baxter; Richard L Whelan
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

2.  Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery.

Authors:  H M C Shantha Kumara; J C Cabot; A Hoffman; M Luchtefeld; M F Kalady; N Hyman; D Feingold; R Baxter; R L Whelan
Journal:  Surg Endosc       Date:  2009-06-24       Impact factor: 4.584

3.  Video-assisted thoracoscopic surgery lobectomy for lung cancer versus thoracotomy: a less decrease in sVEGFR2 level after surgery.

Authors:  Jun Peng; Su An; Hui-Ping Wang; Xin-Long Chen; Xian-Gu Ning; Jun Liu; Xu-Ya Yu; Xin Mao; Tian-Rui Xu
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

4.  Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection.

Authors:  Ewa Kopczyńska; Maciej Dancewicz; Janusz Kowalewski; Roman Makarewicz; Hanna Kardymowicz; Agnieszka Kaczmarczyk; Tomasz Tyrakowski
Journal:  ISRN Oncol       Date:  2012-03-26

5.  Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells.

Authors:  J M Ou; Z Y Yu; M K Qiu; Y X Dai; Q Dong; J Shen; X F Wang; Y B Liu; Z W Quan; Z W Fei
Journal:  Eur J Histochem       Date:  2014-03-17       Impact factor: 3.188

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.